NIAID-funded study could offset harsh effects of antibiotics.
Researchers at Memorial Sloan Kettering Cancer Center have shown that autologous fecal microbiota transplantation (auto-FMT) is a safe and effective way to help replenish beneficial gut bacteria in cancer patients who require intense antibiotics during allogenic hematopoietic stem cell transplantation. In their study, patients who underwent the procedure were randomly assigned into two groups: one group received standard care and the other received auto-FMT. The researchers found that auto-FMT resulted in the recovery of beneficial gut bacteria to near baseline levels within days, thus restoring patients’ digestive, immune and other essential functions. With standard care, beneficial bacteria typically take many weeks to recover from antibiotic treatment, leaving patients at risk of other infectious diseases, including Clostridium difficile.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, provided funding for part of the project. The study report appears in Science Translational Medicine.
“This important study suggests that clinical intervention using auto-FMT can safely reverse the disruptive effects of broad-spectrum antibiotic treatment,” says NIAID Director Anthony S. Fauci, M.D. “If validated in larger studies, this approach may prove to be a relatively simple way to quickly restore a person’s healthy microbiome following intensive antimicrobial therapy.”
Allogenic hematopoietic cell transplantation involves a donor — often but not exclusively a family member — who gives the recipient stem cells that re-establish bone marrow production of blood cells and immune function to combat cancer. Antibiotics are essential to prevent bacterial infections in stem cell recipients. However, antibiotics also destroy beneficial bacteria that enhance immune function and resistance to infection. The loss of beneficial bacteria increases the risk of certain life-threatening infectious diseases and graft-versus-host disease (GVHD).
The study involved cancer patients who provided their own fecal sample, which was frozen and stored prior to their cell transplantation procedure. Weeks later, when physicians confirmed that the transplanted cells were growing, they assessed the status of the patients’ beneficial gut bacteria. The first 25 patients who lacked known beneficial bacteria were enrolled into the study and randomly assigned to the different treatment groups: 14 received auto-FMT by enema and 11 received standard-of-care.
The patients who received auto-FMT consistently regained bacterial diversity, composition and function; recovery of beneficial bacteria in the 11 control patients was delayed.
The researchers are continuing to monitor the study patients to determine if auto-FMT improves patient outcomes, such as the incidence and severity of bacterial, viral and fungal infections and the incidence and severity of GVHD. Whether FMT from a healthy donor would be as beneficial as the patient’s own fecal sample at restoring beneficial bacteria remains to be studied.
The Latest on: Fecal microbiota transplantation
via Google News
The Latest on: Fecal microbiota transplantation
- Alteration of the Intestinal Microbiomeon November 30, 2021 at 4:00 pm
In cases of recurrent C. difficile infection, fecal microbiota transplant (FMT) is a highly effective treatment option promoting the restoration of normal gut microbiota. Furthermore, preliminary ...
- When the gut's internal ecosystem goes awry, could an ancient if gross-sounding treatment make it right?on November 24, 2021 at 2:11 pm
The procedure, known as a fecal microbiota transplant, involves taking stool from a healthy donor and administering it to the patient to add back "good" microbes and reset the gut. At the time it ...
- Chinese Medical Journal Publishes First Consensus on Washed Microbiota Transplantationon November 24, 2021 at 4:39 am
Our gut houses billions of different microbes, each serving its purpose to keep our gut functioning and healthy. The Clostridioides difficile (C. diff) infection ...
- Chinese Medical Journal Publishes First Consensus on Washed Microbiota Transplantationon November 24, 2021 at 12:39 am
WMT is a relatively new procedure for fecal microbiota transplantation (FMT), and its protocols differ from those for performing the traditional crude FMT, which is based on manual preparation.
- VIDEO: Expert discusses new ACG guidelines, importance of microbiotaon November 20, 2021 at 12:55 am
“Once our patients get to that second recurrence or third episode, that’s the scenario where we consider 7 to 10 days of antimicrobials followed by fecal microbiota transplantation,” he sai ...
- Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantationon November 17, 2021 at 4:00 pm
The microbiota composition of fecal samples obtained from patients who were undergoing allogeneic hematopoietic-cell transplantation at four centers was profiled by means of 16S ribosomal RNA gene ...
- FMT Benefits Last a Few Years in Severe Alcoholic Hepatitis Patientson November 14, 2021 at 3:01 pm
Patients with severe alcoholic hepatitis who underwent a fecal microbiota transplant (FMT) had lower rates of complications, alcohol relapse, and a trend towards improved survival 3 years later ...
- FMT restores gut barrier function, improves severe alcohol associated hepatitis outcomeson November 11, 2021 at 4:00 pm
Improvements in intrahepatic and circulatory inflammation markers were observed after fecal microbiota transplantation in patients with severe alcohol associated hepatitis, according to a ...
via Bing News